Effect of national guidance on survival for babies born at 22 weeks’ gestation in England and Wales: population based cohort study
File(s)e000579.full.pdf (1.15 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Objectives To explore the effect of changes in national clinical recommendations in 2019 that extended provision of survival focused care to babies born at 22 weeks’ gestation in England and Wales.
Design Population based cohort study.
Setting England and Wales, comprising routine data for births and hospital records.
Participants Babies alive at the onset of care in labour at 22 weeks+0 days to 22 weeks+6 days and at 23 weeks+0 days to 24 weeks+6 days for comparison purposes between 1 January 2018 and 31 December 2021.
Main outcome measures Percentage of babies given survival focused care (active respiratory support after birth), admitted to neonatal care, and surviving to discharge in 2018-19 and 2020-21.
Results For the 1001 babies alive at the onset of labour at 22 weeks' gestation, a threefold increase was noted in: survival focused care provision from 11.3% to 38.4% (risk ratio 3.41 (95% confidence interval 2.61 to 4.45)); admissions to neonatal units from 7.4% to 28.1% (3.77 (2.70 to 5.27)), and survival to discharge from neonatal care from 2.5% to 8.2% (3.29 (1.78 to 6.09)). More babies of lower birth weight and early gestational age received survival focused care in 2020-21 than 2018-19 (46% to 64% at <500g weight; 19% to 31% at 22 weeks+0 days to 22 weeks+3 days).
Conclusions A change in national guidance to recommend a risk based approach was associated with a threefold increase in 22 weeks’ gestation babies receiving survival focused care. The number of babies being admitted to neonatal units and those surviving to discharge increased.
Design Population based cohort study.
Setting England and Wales, comprising routine data for births and hospital records.
Participants Babies alive at the onset of care in labour at 22 weeks+0 days to 22 weeks+6 days and at 23 weeks+0 days to 24 weeks+6 days for comparison purposes between 1 January 2018 and 31 December 2021.
Main outcome measures Percentage of babies given survival focused care (active respiratory support after birth), admitted to neonatal care, and surviving to discharge in 2018-19 and 2020-21.
Results For the 1001 babies alive at the onset of labour at 22 weeks' gestation, a threefold increase was noted in: survival focused care provision from 11.3% to 38.4% (risk ratio 3.41 (95% confidence interval 2.61 to 4.45)); admissions to neonatal units from 7.4% to 28.1% (3.77 (2.70 to 5.27)), and survival to discharge from neonatal care from 2.5% to 8.2% (3.29 (1.78 to 6.09)). More babies of lower birth weight and early gestational age received survival focused care in 2020-21 than 2018-19 (46% to 64% at <500g weight; 19% to 31% at 22 weeks+0 days to 22 weeks+3 days).
Conclusions A change in national guidance to recommend a risk based approach was associated with a threefold increase in 22 weeks’ gestation babies receiving survival focused care. The number of babies being admitted to neonatal units and those surviving to discharge increased.
Date Issued
2023-11-07
Date Acceptance
2023-08-29
Citation
BMJ Medicine, 2023, 2 (1)
ISSN
2754-0413
Publisher
BMJ Publishing Group
Journal / Book Title
BMJ Medicine
Volume
2
Issue
1
Copyright Statement
Open access This is an open access article distributed in accordance
with the Creative Commons Attribution 4.0 Unported (CC BY 4.0)
license, which permits others to copy, redistribute, remix, transform
and build upon this work for any purpose, provided the original
work is properly cited, a link to the licence is given, and indication
of whether changes were made. See: https://creativecommons.org/
licenses/by/4.0/
with the Creative Commons Attribution 4.0 Unported (CC BY 4.0)
license, which permits others to copy, redistribute, remix, transform
and build upon this work for any purpose, provided the original
work is properly cited, a link to the licence is given, and indication
of whether changes were made. See: https://creativecommons.org/
licenses/by/4.0/
License URL
Identifier
https://bmjmedicine.bmj.com/content/2/1/e000579
Publication Status
Published
Date Publish Online
2023-11-07